In the present study, we analyzed 31 Brazilian women at-risk for hereditary breast/ovarian cancer (27 with personal history of BC and 4 with ovarian tumors) without BRCA1/BRCA2/TP53 germline mutations, by array-CGH. The gene discussed is BRCA2; the disease is ovarian cancer.